>> my mission is simple, to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere and i promise to help you find it. "mad money" starts now. >> hey i'm cramer. welcome to "mad money" welcome to cramerica. other people want to make friends. i'm trying to save you a little money. my job is not just to entertain but to educate. call me at 1-800-743-cnbc. few groups matter as much to the stock market as the retail sector. the visibility, the universal appeal of the group, everyone shops in this country. can impact the entire psyche of

investing, because when retail is weak people assume the whole market is weak too. something that happened again today with the dow falling 65 points. yes and nasdaq, .09%. not a lot of retail on the nasdaq, therefore trying to figure out what the heck is going on in retail and determine whether it's right that this group should be having such a big impact as a whole. these are two different questions and they need to be addressed separately. let's deal with the proximate cause, the elephant in the room. the very poor numbers from best buy. there was a time when best buy would have absolutely killed to have the kind of shortfall reported this morning, with shares barely down, .9%. and some softer gross margins but not deadly. this shortfall sent best buy

down a staggering $10.74, nearly 29%, wasn't just any miss. it was a miss that came on top of a remarkable turnaround. a turn that sucked in analyst after analyst until there was virtually no one left to upgrade. that's quite a change from its unloved state a little over a year ago when best buy was trading only at $11. that was at the end of 2012. best buy stock is the victim of a process i wrote about in "get rich carefully," it became too loved, too amorous. i tell you about how i made the exact point with well point. how universal this process is, in 2011, i got super excited because it kept getting upgraded and upgraded, one after another, wellpoint, just like best buy,

13 months ago lost its allure and got to point where the analyst community hated it. they thought the company would be a casualty of obamacare. once they took a close look at the affordable care act, they realized wellpoint, far from being obama roadkill, was one of biggest beneficiaries from the law. that's right. loathe came to love. each analyst got on board taking, each time they got an upgrade, i was doing high fives with the trust co-portfolio manager stephanie link. so excited what geniuses we looked like. why not? each upgrade cost a short sale or two. the opening bell, again just like each upgrade at best buy spiked the stock. we decided to hold on to wellpoint for the trust, given all of the upgrades, the analysts had to know something, wasn't there something happening in the back room somewhere? wrong. just like best buy, wellpoint

has been levitating precisely because of each upgrade. not because things were getting better at the store but because of the upgrade after upgrade at the top. there was no one left to upgrade. that rocket fuel propelled them higher, coupled with the short sells and that -- that's what happened. it was finally spent. no more good news. best buy got whacked beyond all reason and fell right back to 57 when trust brought it originally. i mentioned earlier, the shorts create stability in the decline when they declare victory and buy stock to close out the positions, but the shorts in wellpoint had already covered and already bought back the stock they shorted because they couldn't take the pain of the repeated upgrades, just like you may not be able to take the pain of the repeated downgrades. there was simply no one left to buy and too many people eager to

sell. in the end, the analysts reacted to the same information and same reasoning over and over and over again in a serial play. in the case of wellpoint, it was the recognition that obamacare wasn't going to decimate the company. in best buy's case it was the realization amazon wasn't going to wip out the company. that's why they were recommending it. but the point is, all of these upgrades that kept driving the stock higher were about the same exact set of facts, just being done on different days. that's how best buy got so hammered today. almost every analyst had gone positive. precisely same thing happened with game stop not that long ago. where analysts had fallen all over themselves to upgrade which caused the stock to rocket far higher than anyone expected, mostly on the backs of short sellers. it became the lone survivor in the industry and benefitting from a new cycle of new video game consoles. just like best buy, you got the comeuppance of a nearly 20% drop

in a single session on tuesday. in other words, this process repeats itself no matter what industry. don't take it so personally if you own best buy. now, let's talk about, so we know how the process of what caused deep declines, we covered that, how could the analysts be so wrong in the first place? that cuts to the second issue. the behavior of the consumer and that's what's gripping the psyche of the stock market. ever since the fall we've begun to believe the consumer was spending aggressively on hardware at the time that they were cooling on apparel. not only had sales been better at best buy but home depot and williams sonoma had good deals. now that thesis after what happened today is in tatters. the crux of the matter is to figure if that's because of

cyclical issues or the unemployment number from last friday or cutoff from unemployment benefits and worries about obamacare. or is it because of secular issues. and buying things on amazon or perhaps just perhaps it is the weird weather patterns that some companies reported and shorter holiday season because of early hanukkah and don't forget a thanksgiving too close to christmas. i talked to enough retailers to know there's been a considerable decline in mall traffic. that is for real. i don't think people suddenly stopped shopping, though. i think they may have altered the behavior of buying online, where they've come to expect the cheapest prices. you know what, that's smart but it's also secular. for example, it's no coincidence that the best performing retailer this holiday season was macy's, which has an omnichannel internet strategy along with cheapest branded products because it has such clout with brands and can drive the best bargains with those companies. the other top two, costco, it's

the new frugality people, just like the generation that lived through the great depression, those who lived through the great recession changed their habits and want closeout merchandise from tjx that they used to find at the higher price department stores, and want club prices inspired by the will not be beat at any price costco. there is a missing piece of the puzzle that will confirm this secular trend, the one toward less mall traffic and more online and more comparison shopping. it would be the sales of amazon which we don't know yet. i'm willing to bet that amazon had a stellar christmas and great january because of its ultralow prices and because of the weather. if i am right, then something else comes into play, the relative cheapness, get this, of amazon, the stock. you have never heard those words together, versus walmart. the largest, but perhaps a faltering retailing. amazon has a market capitalization only $182

billion, $70 billion less than walmart. maybe people are buying amazon here, which is the most asked question i ever get, because it deserves to sell at a bigger capitalization. i'm not backing away from my view that the horrible december unemployment number explains a great deal of what's really happening in the retail picture. there's not enough jobs being created in this country. nor am i backing away from the fact that there are other sectors doing quite well that have nothing to do with retail, hence the nasdaq could be up today. but the bottom line is this, i urge you to accept the giant reset going on in retail. recognizing how the analyst upgrade process can create two great expectations and spending has changed perhaps permanently, or at least until enough retailers retrench or go under to eliminate the supply in a very overstored nation. can i go to larry in massachusetts, please? larry. >> caller: jim, happy new year and happy new book. it's a treasure.

>> you're terrific. thank you so much. >> caller: let me tell you, your mom is selling out there. well, it's deserved. from the book, you mentioned vf corp as the apparel play, and i know that's a snapshot in time when you put the book to bed. is it still a power play over underarmour or or nike? >> i will say that the companies that i picked to highlight there are precisely not the ones i'm thinking in your term -- i'm thinking long term. i think what eric wiseman is doing at vf -- by the way, manny chirico is doing at pvh, will transcend whatever happened this holiday season. i wish vf were down so i could push it more aggressively. let's go to mike in new jersey. >> caller: what's happening, captain? >> not much. how about you? >> caller: good. i appreciate that.

my question is on scott's miracle grow, got in late 2012, it never came back. it's aggressively increasing its dividend, which is good and bad. i like it, should i wait for a pullback? >> let me tell you about how i feel about scott's miracle-gro. there are very few companies i feel like i just am completely weather dependent upon and i can't recommend a stock where the weather plays such a big role. i'll tell you this, i'm a gardener and i absolutely love scott's miracle-gro. if it's raining in april or may, my garden isn't using the stuff, and that's what i'm afraid of. retail matters, that's just one of the market's truths you have to accept. a reset is happening and that's just the kind of therapy, perhaps, that we need. "mad money" will be right back. coming up -- lock it up from the data breaches at target and neiman marcus to the rise in cyber spying, it's never been a better time to protect your identity. can life lock secure your data and be your path to profits?

cramer talks to the ceo. and later, investing indecision. 403bs, 529s, 401 k's. how can you be sure you're on the right path? you've got questions and it's time for answers. tweet @jimcramer #getaplan and get ready to see a different side of cramer's mind when he reveals his new playbook. plus, target cancer. galena biopharma is behind research to help end the recurrence of breast cancer. will the science support the stock's staggering run or could the trials come up empty? cramer talks to the ceo all coming up on "mad money." >> don't miss a second of "mad money" follow @jimcramer on twitter.

have a question, tweet cramer, #madtweets and send jim an e-mail or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com.

in a world where more than your personal data than ever is floating in the cloud, they had their credit card numbers stolen by hackers last month along with a similar data breach at neiman marcus, it's worth thinking how we protect our sensitive information and who wins in this environment where no one's info is safe. i don't have expertise in identity theft but i do know about stocks. lifelock provides identity theft protection services. sign up with them and the company will continuously monitor your credit and identity related events so they can alert you if you have any fraudulent activity. in october 2.9 million subscribers and i think that will go higher.

let me be clear, lifelock is not in the business of stopping something like the target hack. it's much more about alerting you to credit card fraud or identity theft. if your identity gets stolen while you're a subscriber, the company will spend up to a million dollars on lawyers to investigate the situation. the latest quarter was already a blowout. they earned 12 cents a share when the street was only expecting 11 and billings were 32% higher. average revenue increased by 12%. plus 40% of those new customers signed up lifelock's higher-priced ultimate product. after the target story i'll bet the next quarter, which they report in a little over a month, could be even better. lifelock just bought a company called lemon, giving them a digital wallet card that stores your loyalty cards, i.d.s in your phone and lets you conveniently monitor your transactions for fraudulent activity.

stock has given you 18% gain since i recommended in early november. now trading 43 times the earnings estimate, and on the other hand, the estimates are too low, stock could have more upside. let's check in with todd davis, the co-founder, chairman and ceo of lifelock to find out more about his company and where it's headed. welcome to "mad money". thank you for coming on the show. >> glad to be here. >> we're not done here with target, we keep hearing there's another big one out there. >> what we see and what target brings to bear, is that the criminals know where the information is. they know who we have to share it with, and so that's where they target, no pun intended. the vectors of attack change. we do hear there may be more out there. they are doing it at point of sale and magnify that some, it's also debit cards. what does that mean when they empty out your checking or savings account? this is where it brings it to the attention of the consumers. >> let's say i hired you and

someone breached it. how do you layoff the risk? >> we're doing a couple of things. because in the back office what we're doing is we're intertwined with 250 of the nation's big enterprises, eight banks, five of the top six wireless providers. when we see your information to get the new credit card or open the new debit card account or get a new wireless phone, before the transaction is completed, if we see it in our network, we ping you and just say, jim, is this you trying to do the new transaction. we give you the opportunity to say, hey, no, it's not, let's stop the transaction before the damage is done, unlike notifying you after the new credit card has been opened. >> i talked to a satisfied customer of yours who said we still use lifelock and everyone needs to have a service like this. that said, what they do is simple, any time anybody tries to get a credit card, you get an

e-mail notification, chase, citi and other banks also offer these types of services. what's different from yours and do they offer a similar service? >> it's actually very different. in our earliest days we weren't the technology company that we are today. we would see similar credit transactions, new accounts opened on a limited basis, but now we see far more than a credit bureau would see. wireless accounts, and by the way, the criminals know where the credit bureaus don't see. we're seeing those, being able to alert you in real time, which is where the criminals go to monetize it. let me get that new iphone 5s because i can sell that and turn it into money. we'll be able to alert you. there is no way to do it yourself. there is no way for the bureaus to be able to offer that same kind of service because we are that technology and we don't ever sell your data for money. this is all we do. it is unique. we're the only ones that have that same visibility and capability. >> are you able to -- have you been able to alert authorities

to people that you think -- and catch anyone? >> we work with law enforcement. we go out and train law enforcement through something called the fbi leader program. we have trained thousands of law enforcement personnel because we're really about beating this crime. we want to make it hard for criminals to turn it into money. if we can stop them from monetizing your personally identifiable information, this crime will finally go down. in the meantime, 13 years in a row, this is the number one consumer complaint in america. >> how does lemon wallet help us as consumers? >> this is a great acquisition. it provides us the ability on your mobile device to give you that convenience and security. store your card so if you were to lose your physical wallet, you have a digital backup. we also allow you to upload and monitor your transactions. if you happen to be a victim of one of these data breaches like target, what are you worried about? they are telling you watch your transactions.

we can allow you to do that at your convenience, on your mobile device, whenever you want. between our alerts and the fact that we have that million dollar total service guarantee, it really gives people the peace of mind to live freely in this ever-connected world, even when there's data beaches, at the convenience of your cell phone device. >> the banks always say don't worry about it, you're protected, we won't nail you for that, is it not true? >> if it's your credit card. as long as you notify within 30 days of the billing cycle, they reverse the charges and can't hold you liable for more than $50. if they deplete your retirement account or checking or savings account, we're the only ones saying we'll be there for you. you can't call the bank and say somebody took out $500,000, can you reverse that and put it back in? they are going to say no, if they have the credentials then this is like someone going to an

atm, walking away and getting mugged. we as the bank are not responsible for reversing that. we will be there for the lifelock customer. >> todd davis, lifelock ceo. they don't stop the target thing. maybe they do something better, make sure someone doesn't steal you. it's the one thing you must do before you ever invest a penny. cramer reveals it when he cracks open his playbook, next. [ male announcer ] this is the story

of the dusty basement at 1406 35th street the old dining table at 25th and hoffman. ...and the little room above the strip mall off roble avenue. ♪ this magic moment it is the story of where every great idea begins. and of those who believed they had the power to do more. dell is honored to be part of some of the world's great stories. that began much the same way ours did. in a little dorm room -- 2713. ♪ this magic moment ♪ ♪ this magic moment fifteen minutes could save you fifteen percent or more on car insurance. everybody knows that parker. well, did you know auctioneers make bad grocery store clerks? that'll be $23.50. now .75, 23.75, hold 'em. hey now do i hear 23.75? 24! hey 24 dollar, 24 and a quarter, quarter, now half, 24 and a half and .75! 25! now a quarter, hey 26 and a quarter, do you wanna pay now, you wanna do it, 25 and a quarter - sold to the man in the khaki jacket!

geico. fifteen minutes could save you... well, you know.

i've always felt we do people a huge disservice in this country because we don't teach financial literacy here in america. i don't know, maybe i'm crazy for believing that knowing how to handle your money is way more important as a life skill than high school chemistry or the dozens of classes you probably take in college that have no relationship with the real world. starting tonight i'm going to run a segment every week called cramer's playbook, where i help you figure out the financial basics and help callers and tweeters come up with plans for saving and investing. for some more tools, check out yourmoney.cnbc.com.

some good stuff up there. i want to answer an incredibly important question we don't address nearly enough here. as i was perusing through the hashtag get a plan tweets, the younger viewers recently out of college want to know how they can get started in savings and investing. take a look at this tweet from @count_von-doom, get a plan. what would you suggest as a starting point? here's the thing. you know i believe the stock market is the greatest wealth creation engine in the history of the universe. you know that i'm relentless to convince you to have exposure to the market, even on ugly days. you know i think it's possible for regular people to beat the averages by doing their own

homework and picking stocks in a diversified portfolio of five to ten names. i can demonstrate that over and over again. as much as i absolutely adore the stock market, the truth is, it's not for everybody. i'm not talking about your disposition here or your willingness to do research or anything like that. i'm referring to some cold, hard, and brutal truths that make investing in stocks pointless, unless you already have a sound financial foundation. think of your stock portfolio and your retirement savings and 401(k) plans and iras as being like a house. before you can build these investments you need to make sure you have a foundation that is actually sound and not this -- >> the house of pain. >> if you don't have your finances in order, you could make huge gains and they'll get eaten by debts and expenses. the first thing i would say is, be sure you're actually ready to invest in the stock market. a lot of people aren't. i'm not criticizing anyone's character here. i believe anyone willing to do

the work can make a killing in stocks, but only if they are not losing a fortune elsewhere. with that in mind, let me give you the sine qua nons of investing, what you absolutely must have before you start putting your money into stocks, before. do not get started investing until you've paid off all of your high interest rate debt. okay? all high interest rate debt got to be paid. i'm talking about credit cards here, people. nobody wants to hear this stuff, but it's my job to be your financial coach and help you become better at managing your money. and the truth is, as long as you keep a balance on even one credit card, you've got no business investing in stocks. you're wrong. i used to feel like you and feel like you don't need to tell me this, right? isn't that how you feel? sometimes it seems like everybody else in the universe is telling you to cut up your credit cards, but whatever those people are saying, it doesn't seem to be working. let me lay out the bare facts, the average rate on a new credit

card is about 15%. that means if you're carrying a balance it's going to gobble up your money at a pretty rapid pace. i know you're thinking, cramer, s&p 500 last year dividends up 32.3%, much more than you would be paying on truly extortionate credit card, and it is true that in 2013 your gains would have outpaced any losses from paying the interest on your credit card. but 2013 was an incredibly good year and 2012 it was up 16% and 2011, just 2%. all three of these years, credit card debt would have canceled out any dollar invested in the market or worse. before you buy stocks build a firm financial foundation by paying off your credit card debt and paying your balance in full every month. if the stock market is an incredible capitalist engine of wealth creation, credit card debt is a vicious tool of wealth destruction. let me point out it's perfectly okay to invest in stocks when you have lower interest rate debt. say you have student loans,

right now those will typically run between 3.8% and 6.4%. i believe you can consistently do better than that in the stock market. you don't need to pay off all of your student loan debt before you start investing. investing in stocks, i believe can help you pay off your student loans. did for me. same goes for your mortgage. just the high interest rate debt that you find on credit cards that has to be eliminated before you start owning stocks. what else do you need before you can start investing? you have no excuse not to have health insurance, none. i don't care if you're politically opposed to the law or not, it's idiotic to pay the government a fine when you can shell out a similar amount of money for insurance coverage. you don't want to end up in a situation where you get very sick very fast and end up paying enormous money out of your pocket costs, especially since hospitals charge individuals higher prices than they charge insurance companies. they can annihilate your wealth,

which is why i've always maintained it's foolish to own stocks if you don't own a health insurance policy first. as much as you know what i do, i love the stock market. before you can actually start investing, you need to get a plan. pay off the credit card debt, start with the highest interest rate cards and work your way down. carrying a balance is anathema to real wealth. if for some crazy reason you don't have health insurance, come on, people, that's also essential to building a solid financial foundation. not to mention avoiding the obamacare penalty, which will gobble up 1% of your income this year if you're not insured. once you have that foundation, then you can start worrying about picking stocks. keep your concerns coming @jimcramer #getaplan. we'll build your financial future together. ♪

♪ [ male announcer ] old el paso frozen entrées.

it is time for the lightning round on cramer's "mad money." what's that about? rapid fire calls. you say the name of the stock and i tell you whether to buy or sell. are you ready skee-daddy? time for the lightning round. let's start with dave in florida. >> caller: james. hold or sell? >> you might as well be in the best one, which is stratus. byron in north carolina. >> caller: how are you doing? >> real good, how about you? >> caller: good. i got a question about lsi, wondering why it's not moving. to my knowledge, it's over the distribution with apple iphone -- >> it got a takeover bid. it is sky works which is still creeping up after the bell.

let's go to navjeed in new york. >> caller: hi, jim, this is navjeed from new york. i just wanted to say that i appreciate all that you do and because of you i know how to apply the homework to my investment decision. >> that's what i want. >> caller: i would like to get your take on symbol ifil. >> we just had a call on lsi, it's a good stock but it's been out there forever. i'm going to recommend it. let's go to mark in wisconsin. >> caller: alexus, exel, a small biotech. >> this is one we like but please understand it's really speculative. bob in california? >> caller: sunny and warm hermosa beach, california. >> i love hermosa beach, what's up? >> caller: jim months ago i bought -- >> lowe's is good but home depot is better. frank in new york. frank? >> mr. cramer, how are you? >> real good.

>> caller: very good. just about to have some dinner with my wife and i've been a very long term holder of walt disney, and i want to know if you think i should stick with it. >> i would say bob iger is one of my bankable 21 in get rich carefully and understand a couple points risk because it moved up and if you want to have 100 shares, buy 50 now and 50 later. i'm going to brandon in new jersey. brandon. >> caller: yes. >> go ahead, brandon. >> caller: i have -- >> we like the stock. it's just up 42%. i'm not -- up 42% now, i'm going to have to say it's got to cool off. we did like it lower. that is the conclusion of the lightning round! >> the lightning round is sponsored by td ameritrade. coming up -- target cancer.

galena biopharma is behind research to help end the recurrence of breast cancer. will its science support the stock's staggering run, or could the company's trials come up empty? cramer talks to the ceo. change in after-market trading. ♪ all the tech stocks with a market cap... of at least 50 billion... are up on the day. 12 low-volume stocks... breaking into 52-week highs. six upcoming earnings plays... that recently gapped up. [ male announcer ] now the world is your trading floor. get real-time market scanning wherever you are with the mobile trader app. from td ameritrade.

i spent a lot of time telling you about the rise of biotech followed by the four horseman of the big pharma apocalypse. this is among my favorite trends, highlighted as a theme built to last in get rich carefully. $2.67, up, this theme has a lot of legs. if you're looking at biotech stocks with huge gains, the big ones are not the way to go. speculate on small cap firms that might have enormous long term potential. look at intercept pharma last week, although to be fair, they gave up 190 points this monday and tuesday. when you have a massive speculative gain, take the money and run, steve miller style.

which brings me to a small and very controversial $750 million company, galena biopharma, a name i got asked about last week. at the time trading at 6 bucks, gave it my blessing now up to $7.48. 18% gain in a week's time. galena is an oncology play and a new vaccine to prevent the recurrence of breast cancer in people who have already survived the disease. it is in phase three trials but thestreet.com's biotech expert, a company a founded, has been skeptical about the science behind the phase two study. personally, after galena's incredible run, i think it's reasonable to take a little off the table. bulls make money, bears make money, hogs get slaughtered. i think it needs more research. we're going straight to the

source. the president and ceo of galena. welcome to "mad money". >> great to be here. >> we have some recent news. you announced this week a partnership for neuvax in india, the commercial rights to neuvax, what did they anticipate they could get out of the deal with galena? >> they have already shown promise and potential in breast cancer, and we're using it to prevent breast cancer recurrence for the 200,000 newly-diagnosed women every year, just in the united states alone, that get to be cancer survivors but live with that fear of 25% of whom have a recurrence of their disease within three years. we've shown some exciting, promising studies that have shown that we can prevent or delay that recurrence significantly, and we're already in a phase three in 15 countries and 700 patients to show we can bring those benefits to people in a commercial area and address a multibillion dollar opportunity.

the deal with dr. ready is significant because it gets us into a whole new tumor type. it goes from breast cancer to gastric cancer. now we've got a study from a risk management standpoint and a study in monotherapy or by itself, a study in combination with the $7 billion drug by roche and genentech, and breast cancer and gastric cancer. we're trying to expand and broaden the utility of this agent in a number of novel areas. >> okay, now, piper jaffray has a buy on your stock was saying that one of the phase three present trials has gone slower than expected and we anticipate data mid 2017, a year later, should we take therefore there are setbacks in the trials? >> no, like anything doing research you have to get set up. we're in 130 hospitals in 15

countries spanning from north america to western europe, eastern europe and israel, and it takes time to get those set up and we're now in a pace and progression where we'll have it fully enrolled by mid-year, and then interim analysis where we have about a year's time. then the full answer if you will in the end of phase three. in the meantime, we're continuing to work on our combination study and then get this 90 patient phase two in gastric cancer off the board. >> doctor, there has been some controversy, i know in seeking -- there are some no name people who have been very vociferous in favor and adam has been adamant that you have -- let's just say cherry picked the good news in the study. how do you respond to -- and i'll just be very specific,

galena cherry picks a subgroup of patients where it said it works but ignores another equal subgroup where it hurts patients even though it should work better for these latter patients. >> well, i can only go back to the actual data. we've got a great group of physicians who work on neuvax and put their patients, and they have the most at stake for anybody who is looking to treat and explore the innovation that neuvax can provide. we've gotten over 500 patients that have seen neuvax. it is a targeted agent, so one of the things in clinical science is you have to figure out who is most likely to benefit. so for example, in herceptin, it only works for 20% to 30% of the patients. we're looking at 50% to 60% of the patients. we framed what we think are the people who could most benefit from the drug.

her two, one plus, two plus, a type that perceptin doesn't address. we think we're addressing a multimillion dollar opportunity and we have the right patients and the right trial and concurrence with the fda for a special protocol assessment. this is a pre-review of what the protocol looks like, and putting ourselves in a position where we can present this medication for patients who can most likely benefit from the treatment for neuvax. >> because we all know people or have lost people who are close to us, who have had breast cancer, i'm trying to be as skeptical as i can. we found a university of pennsylvania study that said cancer vaccines like neuvax are ineffective. don't know what to say. university of pennsylvania a pretty good place. >> outstanding place. and this is the nature of these drugs. i've worked on many drugs in my

past experience, as have my colleagues. terrific group. we've brought in neuvax from the md anderson cancer center and i can tell you in our phase two study, in 187 patients in the patient -- exact same patient population that we're studying for the phase three, those patients had 23% of the control patients are placebo patients, 23% of them had a recurrence at three years. zero percent of the patients on neuvax had a recurrence in that same time point. we were excited to take it to the fda and negotiate the special protocol assessment and getting the patients into phase three in a randomized study, double blinded to answer the question definitively, once and for all. i would point that every innovation or technology platform goes through this appropriate period of skepticism and interrogation by clinical trials and good science.

that's what we're trying to do. this is a large, blinded, randomized study. if approved it will address a large unmet medical need. so good science takes time. we think we're doing the right trial. we've got the right providence of these places and md anderson is as good as it gets in united states and the world in terms of innovation and moving important technologies forward. >> thank you so much for coming on "mad money." your company has great interest in our viewers and i'm glad you're a good spokesman for galena biopharma. >> thank you sir. >> thank you. >> the president and ceo of galena biopharma, read the stories. there's lots of information both pro and con. be an informed investor. stay with cramer.

>> there's nothing like a hated story. as i signed copies of my book last night at the 92nd street y in manhattan, perhaps one of the most knowledgeable audiences you get, my idea of buying bank of america met with resistance. no one is saying you have no idea what you're doing. it has to do with my insistence

i can't find a metric to recommend twitter. that's what you do when you're desperate to get momentum and i have enough problems backing amazon and netflix. it's bank of america they don't trust. the company is run by some lawyer who doesn't know how to run a bank. i think the bank of america was entirely dysfunctional put together on the fly with the worst possible acquisition of the year, countrywide at its center piece. this target which financed 20% of the 2006 mortgages of this country was less than worthless. we don't have the exact tally but it's entirely possible almost all of these mortgages defaulted. i don't know a soul who could have managed that poison pill properly. second indictment, the liabilities haven't gone away, judging by the $2 billion litigation, this could be the beginning of a second round of putbacks. there are more issues to set and more liabilities. it could indicate there might be as much, call it $8 billion. but they still made $3 billion after the charge, and it can handle eight billion easily. all i can say is the size of the

dividend is not up to bank of america. lots of people think the regulators have gone away, but not for banks, particularly banks that were in as much trouble as bank of america was. the last time the balance sheet was in as good shape it was now was 2006 and paid a dividend of 2 bucks. the stock went up gigantic yield if it can pay $2 a share again. it is not up to brian moynahan. it's not up to the bank. it's up to the government. fourth negative assumption, the company will be worth more if it broke itself up. i think we saw tremendous synergy and merrill had the best investment numbers of the period, unbelievable. that's right. it's number one. just to be sure of the major banks that reported, let's rank them, bank of america, pnc, jp morgan and then citigroup, they pulled up the rear. finally fifth, there is a belief that without a mortgage pickup, and we know there isn't one, this one has no earnings

momentum. the mortgage business, people, is a commodity business. all right, it's one of the worst parts of any bank right now. what really matters is the net interest margin, which is truly a function of deposits in the yield curve. it will simply coin money as interest rates go higher. deposit growth was almost -- it was almost double digits, leverage will be immense at bank of america. you want fewer mortgages and more deposits. that's what they are giving you. walking over to the y last night, a man said bank of america, really cramer? still really cheap. he made an allusion with how much money he could have made with tips like this one, scornful. another person asked, do you know how much money i lost on bank of america? i don't care where the stock is coming from. i care where it's going to. all its done is back to where it was in 2011, it's down 55 -- down from 55 in 2006, i think it

has the most upside of any bank i follow. sorry, i wish i could be more negative, but the bear case -- not there. the bull case is. stick with cramer. ♪ ♪ [ male announcer ] old el paso frozen entrées. now in freezers. a body at rest tends to stay at rest... while a body in motion tends to stay in motion.

staying active can actually ease arthritis symptoms. but if you have arthritis, staying active can be difficult. prescription celebrex can help relieve arthritis pain so your body can stay in motion. because just one 200mg celebrex a day can provide 24 hour relief for many with arthritis pain and inflammation. plus, in clinical studies, celebrex is proven to improve daily physical function so moving is easier. celebrex can be taken with or without food. and it's not a narcotic. you and your doctor should balance the benefits with the risks. all prescription nsaids, like celebrex, ibuprofen, naproxen and meloxicam have the same cardiovascular warning. they all may increase the chance of heart attack or stroke, which can lead to death. this chance increases if you have heart disease or risk factors such as high blood pressure or when nsaids are taken for long periods. nsaids, like celebrex, increase the chance of serious skin or allergic reactions or stomach and intestine problems, such as bleeding and ulcers, which can occur without warning and may cause death. patients also taking aspirin and the elderly

are at increased risk for stomach bleeding and ulcers. don't take celebrex if you have bleeding in the stomach or intestine, or had an asthma attack, hives, other allergies to aspirin, nsaids or sulfonamides. get help right away if you have swelling of the face or throat, or trouble breathing. tell your doctor your medical history. and find an arthritis treatment for you. visit celebrex.com and ask your doctor about celebrex. for a body in motion. over the pizza place on chestnut street the modest first floor bedroom in tallinn, estonia and the southbound bus barreling down i-95. ♪ this magic moment it is the story of where every great idea begins. and of those who believed they had the power to do more. dell is honored to be part of some of the world's great stories. that began much the same way ours did. in a little dorm room -- 2713. ♪ this magic moment ♪

just what we were afraid of. so many upgrades at intel the last few days, a little reminiscent of best buy. look into buying some more. always a bull market somewhere. right here on "mad money." i'm jim cramer and i'll see you tomorrow. u.s. history. >> narrator: a mysterious ring of social outcasts with an insatiable appetite for sex, drugs, and your encrypted information. >> it was a very fine line between exploiting a system to check it out or exploiting a system for gain. >> they were looking for data any way they could get it. >> narrator: they steal credit-card numbers and make a fortune by selling them on the black market. >> it just kept building upon itself -- 500,000 numbers, then a million numbers, up to 130 million numbers. >> you or i might be a victim of